Market Closed -
Hong Kong S.E.
01:38:22 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.098
HKD
|
+13.95%
|
|
-14.04%
|
-32.41%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
201.2
|
160.2
|
167.6
|
595
|
241.9
|
65.31
|
Enterprise Value (EV)
1 |
138.6
|
146.7
|
173.2
|
600.7
|
228.6
|
56.73
|
P/E ratio
|
-1.36
x
|
-5.99
x
|
-4.85
x
|
-14.4
x
|
-13.4
x
|
-0.71
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.29
x
|
1.43
x
|
2.48
x
|
11.1
x
|
3.36
x
|
0.94
x
|
EV / Revenue
|
1.58
x
|
1.31
x
|
2.56
x
|
11.2
x
|
3.18
x
|
0.82
x
|
EV / EBITDA
|
-7.52
x
|
-12.3
x
|
-13.5
x
|
-18.8
x
|
-19.2
x
|
-0.66
x
|
EV / FCF
|
-9.03
x
|
-4.61
x
|
-859
x
|
-56.3
x
|
18.5
x
|
9.85
x
|
FCF Yield
|
-11.1%
|
-21.7%
|
-0.12%
|
-1.78%
|
5.42%
|
10.2%
|
Price to Book
|
1.21
x
|
1.18
x
|
1.58
x
|
4.5
x
|
2.11
x
|
3.51
x
|
Nbr of stocks (in thousands)
|
3,72,536
|
3,72,536
|
3,72,536
|
4,83,776
|
4,83,776
|
4,83,776
|
Reference price
2 |
0.5400
|
0.4300
|
0.4500
|
1.230
|
0.5000
|
0.1350
|
Announcement Date
|
24/04/18
|
25/04/19
|
23/04/20
|
30/04/21
|
28/04/22
|
28/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
87.93
|
112.3
|
67.71
|
53.77
|
71.89
|
69.21
|
EBITDA
1 |
-18.42
|
-11.9
|
-12.85
|
-32.02
|
-11.91
|
-86.45
|
EBIT
1 |
-19.7
|
-12.58
|
-13.34
|
-32.11
|
-11.96
|
-86.73
|
Operating Margin
|
-22.41%
|
-11.21%
|
-19.71%
|
-59.73%
|
-16.63%
|
-125.32%
|
Earnings before Tax (EBT)
1 |
-147.9
|
-26.77
|
-34.8
|
-35.54
|
-18.11
|
-104.3
|
Net income
1 |
-147.9
|
-26.75
|
-34.55
|
-34.97
|
-18.11
|
-104.3
|
Net margin
|
-168.23%
|
-23.83%
|
-51.02%
|
-65.04%
|
-25.19%
|
-150.64%
|
EPS
2 |
-0.3971
|
-0.0718
|
-0.0927
|
-0.0855
|
-0.0374
|
-0.1913
|
Free Cash Flow
1 |
-15.35
|
-31.8
|
-0.2018
|
-10.67
|
12.38
|
5.759
|
FCF margin
|
-17.46%
|
-28.32%
|
-0.3%
|
-19.84%
|
17.22%
|
8.32%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/04/18
|
25/04/19
|
23/04/20
|
30/04/21
|
28/04/22
|
28/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
5.59
|
5.61
|
-
|
-
|
Net Cash position
1 |
62.5
|
13.5
|
-
|
-
|
13.3
|
8.58
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.4351
x
|
-0.1751
x
|
-
|
-
|
Free Cash Flow
1 |
-15.3
|
-31.8
|
-0.2
|
-10.7
|
12.4
|
5.76
|
ROE (net income / shareholders' equity)
|
-63.1%
|
-17.7%
|
-28.5%
|
-29.3%
|
-14.7%
|
-156%
|
ROA (Net income/ Total Assets)
|
-4.38%
|
-3.4%
|
-3.91%
|
-9.9%
|
-3.76%
|
-30.3%
|
Assets
1 |
3,377
|
786.4
|
884.1
|
353.3
|
481.7
|
343.9
|
Book Value Per Share
2 |
0.4400
|
0.3600
|
0.2900
|
0.2700
|
0.2400
|
0.0400
|
Cash Flow per Share
2 |
0.0700
|
0.0500
|
0.0300
|
0.0100
|
0.0100
|
0.0100
|
Capex
1 |
0.5
|
0
|
0.35
|
-
|
1.4
|
-
|
Capex / Sales
|
0.56%
|
0%
|
0.52%
|
-
|
1.95%
|
-
|
Announcement Date
|
24/04/18
|
25/04/19
|
23/04/20
|
30/04/21
|
28/04/22
|
28/04/23
|
|
1st Jan change
|
Capi.
|
---|
| -32.41% | 10.65M | | +73.46% | 12.41B | | -15.61% | 8.12B | | +3.88% | 6.59B | | +14.69% | 5.46B | | +42.58% | 5.05B | | -19.05% | 4.02B | | -32.61% | 2.47B | | -0.74% | 2.02B | | +10.80% | 1.89B |
Medical Equipment
|